Rubric Capital Management LP 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,333,893 3.050% |
-601,464 (-31.08%) |
Filing |
| 2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,935,357 5.350% |
99,970 (+5.45%) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Rubric Capital Management LP | 1,835,387 5.970% |
1,835,387 (New Position) |
Filing |